Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component of a cutting-edge immunotherapy treatment that utilizes CAR T cells, which are immune cells engineered to specifically target and destroy cancer cells.
What sets this antibody apart is its exceptional ability to bind to a specific protein found on glioblastoma cells, making the CAR T cells incredibly effective at eliminating the cancer. In studies with mice, this new treatment has shown remarkable results, not only eradicating existing tumors but also preventing new ones from forming.
This discovery holds immense promise for patients diagnosed with glioblastoma, offering a potential breakthrough in the fight against this aggressive disease.
เงินทุน
Not explicitly stated in the article.
กระดาษต้นฉบับ
ชื่อบทความต้นฉบับ: Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
วารสาร: รายงานทางวิทยาศาสตร์
ดอย: https://doi.org/10.1038/s41598-024-79339-6